A Study to Explore the Efficacy of JNJ-89495120 in the Treatment of Major Depressive Disorder

Running, not enrolling · Phase 2 · Has a placebo group

Conditions studied: Depressive Disorder, Major

In brief

The purpose of this study is to evaluate how well JNJ-89495120 works (anti-depressant effects) and how well it is tolerated as compared to placebo on reducing the symptoms of depression in participants with major depressive disorder (MDD).

Key facts

Study ID
NCT06785012
Run by
Janssen Research & Development, LLC
People needed
107
Starts
2024-12-26
Expected to finish
2026-08-10
Last updated by the study team
2026-07-31

Who can join

Age: 18 and older, up to 64. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.